Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,468,243
-
Total 13F shares
-
51,219,533
-
Share change
-
-183,839
-
Total reported value
-
$299,625,643
-
Put/Call ratio
-
52%
-
Price per share
-
$5.84
-
Number of holders
-
101
-
Value change
-
-$24,705,356
-
Number of buys
-
56
-
Number of sells
-
47
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q1 2019
As of 31 Mar 2019,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,219,533 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Palo Alto Investors LP, Consonance Capital Management LP, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Candriam Luxembourg S.C.A., CITADEL ADVISORS LLC, FMR LLC, and EMERALD ADVISERS, LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.